Abstract
Breast cancer is the most common malignancy diagnosed in women (http://seer.cancer.gov/statfacts/html/breast.html). Today, with the widespread generalization of mammography, it is most frequently diagnosed at an early stage (Nystrom et al. 2002). The outcomes of those early-stage cancers are excellent, with local control above 98% and a risk of dying of cancer at 5 years below 2% (http://seer.cancer.gov/statfacts/html/breast.html; Strnad et al. 2016). Clinical researches since the 1980s have aimed at optimizing the cosmetic outcome, minimizing the long-term side effects, and reducing the treatment burden. Several randomized clinical trials and meta-analyses have shown that breast-conserving surgery followed by adjuvant radiotherapy (XRT) to the whole breast achieves local control rate and survival equivalent to mastectomy, with the advantage of allowing breast conservation and hence improved quality of life (Fisher et al. 2002; Veronesi et al. 2002; Clark et al. 1996; EBCTCG et al. 2011).
The original version of this chapter was revised. The affiliations of the authors have been updated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
cancer.gov. http://seer.cancer.gov/statfacts/html/breast.html. Accessed 11 Oct 2016
Atkins HL (1964) Massive dose technique radiation therapy of inoperable carcinoma of the breast. Am J Roentgenol 91:80
Bates TD (1988) The 10-year results of a prospective trial of post-operative radiotherapy delivered 3 fractions per week versus 2 fractions per week in breast carcinoma. Br J Radiol 61:625–630
Brunt AM, Wheatley D, Yarnold J et al (2016) Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial. Radiother Oncol 120:114–118
Budach W, Bölke E, Matuschek C (2015) Hypofractionated radiotherapy as adjuvant treatment in early breast cancer. A review and meta-analysis of randomized controlled trials. Breast Care 10:240–245. doi:10.1159/000439007
Caudrelier JM, Truong PT (2015) Role of hypofractionated radiotherapy in breast locoregional radiation. Cancer Radiother 19:241–247. doi:10.1016/j.canrad.2015.02.012
Chan EK, Woods R, McBride ML et al (2014) Adjuvant hypofractionated versus conventional whole breast radiation therapy for early-stage breast cancer: long-term hospital-related morbidity from cardiac causes. Int J Radiat Oncol Biol Phys 88:786–792. doi:10.1016/j.ijrobp.2013.11.243
Chan EK, Woods R, Virani S et al (2015) Long-term mortality from cardiac causes after adjuvant hypofractionated vs. conventional radiotherapy for localized left-sided breast cancer. Radiother Oncol 114:73–78. doi:10.1016/j.radonc.2014.08.021
Chan EK, Tabarsi N, Tyldesley S et al (2016) Patient-reported long-term cosmetic outcomes following short fractionation whole breast radiotherapy with boost. Am J Clin Oncol 39:473–478. doi:10.1097/COC.0000000000000084
Ciammella P, Podgornii A, Galeandro M et al (2014) Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors. Radiat Oncol 9:97. doi:10.1186/1748-717X-9-97
Clark RM, Whelan T, Levine M et al (1996) Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 88:1659–1664
Courdi A, Ortholan C, Hannoun-Lévi JM et al (2006) Long-term results of hypofractionated radiotherapy and hormonal therapy without surgery for breast cancer in elderly patients. Radiother Oncol 79:156–161
Darby SC, Ewertz M, McGale P et al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368:987–998. doi:10.1056/NEJMoa1209825
Delaney GP, Gandhidasan S, Walton R et al (2016) The pattern of use of hypofractionated radiation therapy for early-stage breast cancer in New South Wales, Australia, 2008 to 2012. Int J Radiat Oncol Biol Phys 96:266–272. doi:10.1016/j.ijrobp.2016.05.016
Dellas K, Vonthein R, Zimmer J, ARO Study Group et al (2014) Hypofractionation with simultaneous integrated boost for early breast cancer: results of the German multicenter phase II trial (ARO-2010–01). Strahlenther Onkol 190:646–653
Donovan E, Bleakley N, Denholm E et al (2007) Randomized trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 82:254–264
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Darby S, McGale P et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378:1707–1716
Edelman AH, Holtz S, Powers WE (1965) Radiotherapy for inoperable carcinoma of the breast. Am J Roentgenol 9:585
Ellerbroek N, Martino S, Mautner B et al (2003) Breast-conserving therapy with adjuvant paclitaxel and radiation therapy: feasibility of concurrent treatment. Breast J 9:74–78
Fisher B, Bauer M, Margolese R et al (1985) Five-year results of a randomized trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312:665–673
Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233–1241
Fletcher GH (1991) Hypofractionation: lessons from complications. Radiother Oncol 20:10–15
Grann A, McCormick B, Chabner ES et al (2000) Prone breast radiotherapy in early-stage breast cancer: a preliminary analysis. Int J Radiat Oncol Biol Phys 47:319–325
Halyard MY, Pisansky TM, Dueck AC et al (2009) Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831. J Clin Oncol 27:2638–2644. doi:10.1200/JCO.2008.17.9549
Haviland JS, Owen JR, Dewar JA et al (2013) The UK Standardization of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomized controlled trials. Lancet Oncol 14:1086–1094. doi:10.1016/S1470-2045(13)70386-3
Herbert C, Nichol A, Olivotto I et al (2012) The impact of hypofractionated whole breast radiotherapy on local relapse in patients with Grade 3 early breast cancer: a population-based cohort study. Int J Radiat Oncol Biol Phys 82(5):2086–2092
Holloway CL, Panet-Raymond V, Olivotto I (2010) Hypofractionation should be the new ‘standard’ for radiation therapy after breast conserving surgery. Breast 19:163–167. doi:10.1016/j.breast.2010.03.002
Jagsi R, Griffith KA, Heimburger D et al (2014) Choosing wisely? Patterns and correlates of the use of hypofractionated whole-breast radiation therapy in the state of Michigan. Int J Radiat Oncol Biol Phys 90:1010–1016. doi:10.1016/j.ijrobp.2014.09.027
Jagsi R, Griffith KA, Boike TP et al (2015) Differences in the acute toxic effects of breast radiotherapy by fractionation schedule: comparative analysis of physician-assessed and patient-reported outcomes in a large multicenter cohort. JAMA Oncol 1:918–930. doi:10.1001/jamaoncol.2015.2590
Khan A, Haffty B (2010) Hypofractionation in adjuvant breast radiotherapy. Breast 19:168–171
Kirova YM, Campana F, Savignoni A et al (2009) Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy. Int J Radiat Oncol Biol Phys 75:76–81. doi:10.1016/j.ijrobp.2008.11.005
Ko DH, Norriss A, Harrington CR et al (2015) Hypofractionated radiation treatment following mastectomy in early breast cancer: the Christchurch experience. J Med Imaging Radiat Oncol 59:243–247. doi:10.1111/1754-9485.12242
Lalani N, Paszat L, Sutradhar R et al (2014) Long-term outcomes of hypofractionation versus conventional radiation therapy after breast-conserving surgery for ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys 90:1017–1024. doi:10.1016/j.ijrobp.2014.07.026
Lee LJ, Harris JR (2009) Innovations in radiation therapy (RT) for breast cancer. Breast 18:S103–S111. doi:10.1016/S0960-9776(09)70284-X
Matthews JH, Meeker BE, Chapman JD (1989) Response of human tumor cell lines in vitro to fractionated irradiation. Int J Radiat Oncol Biol Phys 16:133–138
McGale P, Darby SC, Hall P et al (2011) Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol 100:167–175. doi:10.1016/j.radonc.2011.06.016
Montague ED (1968) Experience with altered fractionation in radiation therapy of breast cancer. Radiology 90:962–966
Mukesh MB, Barnett GC, Wilkinson JS et al (2013) Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis. J Clin Oncol 31:4488–4495
Mulliez T, Veldeman L, van Greveling A et al (2013) Hypofractionated whole breast irradiation for patients with large breasts: a randomized trial comparing prone and supine positions. Radiother Oncol 108:203–208. doi:10.1016/j.radonc.2013.08.040
Nystrom L, Andersson I, Bjurstam N et al (2002) Long-term effects of mammography screening: updated overview of the Swedish randomized trials. Lancet 359:909–919
Ortholan C, Hannoun-Lévi JM, Ferrero JM et al (2005) Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients. Int J Radiat Oncol Biol Phys 61:154–162
Overgaard M (1985) The clinical implications of non-standard fractionation. Int J Radiat Oncol Biol Phys 11:1225–1226
Owen JR, Ashton A, Bliss JM et al (2006) Effect of radiotherapy fraction size on tumour control in patient with early-stage breast cancer after local tumour excision: long-term results of randomized trial. Lancet Oncol 7:467–471
Pignol JP, Olivotto I, Rakovitch E et al (2008) A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 26:2085–2092. doi:10.1200/JCO.2007.15.2488
Pignol JP, Truong P, Rakovitch E et al (2016) Ten years results of the Canadian breast intensity modulated radiation therapy (IMRT) randomized controlled trial. Radiother Oncol. doi:10.1016/j.radonc.2016.08.021. [Epub ahead of print]
Rodger A (2010) Should fewer fractions be the new standard for postoperative radiotherapy in patients with early breast cancer? Breast 19:157–158. doi:10.1016/j.breast.2010.03.006
Schultheiss TE (2008) The radiation dose-response of the human spinal cord. Int J Radiat Oncol Biol Phys 71:1455–1459
START Trialists’ Group, Bentzen SM, Agrawal RK et al (2008b) The UK Standardization of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trial. Lancet Oncol 9:331–341. doi:10.1016/S1470-2045(08)70077-9
START Trialists’ Group, Bentzen SM, Agrawal RK, Aird EG et al (2008a) The UK Standardization of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trial. Lancet 371:1098–1107
Steel GG, Deacon JM, Duchesne GM et al (1987) The dose-rate effect in human tumour cells. Radiother Oncol 9:299–310
Strnad V, Ott OJ, Hildebrandt G, Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO) et al (2016) 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomized, phase 3, non-inferiority trial. Lancet 387:229–238. doi:10.1016/S0140-6736(15)00471-7
Tian S, Paster LF, Kim S et al (2016) Comparison of mammographic changes across three different fractionation schedules for early-stage breast cancer. Int J Radiat Oncol Biol Phys 95:597–604. doi:10.1016/j.ijrobp.2016.01.056
Tjessem KH, Johansen S, Malinen E et al (2013) Long-term cardiac mortality after hypofractionated radiation therapy in breast cancer. Int J Radiat Oncol Biol Phys 87:337–343. doi:10.1016/j.ijrobp.2013.05.038
Veronesi U, Cascinelli N, Mariani L et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347(16):1227–1232
Versmessen H, Vinh-Hung V, Van Parijs H et al (2012) Health-related quality of life in survivors of stage I–II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy. BMC Cancer 12:495. doi:10.1186/1471-2407-12-495
Vicini FA, Sharpe M, Kestin L et al (2002) Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 54:1336–1344
Wazer DE, Kaufman S, Cuttino L et al (2006) Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcomes after high dose rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys 64:489–495
Whelan T, MacKenzie R, Julian J et al (2002) Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94:1143–1150
Whelan TJ, Kim DH, Sussman J (2008) Clinical experience using hypofractionated radiation schedules in breast cancer. Semin Radiat Oncol 18:257–264
Whelan TJ, Pignol JP, Levine MN et al (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 362:513–520. doi:10.1056/NEJMoa0906260
Yarnold J, Ashton A, Bliss J et al (2005) Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomized trial. Radiother Oncol 75:9–17
Yu TK, Whitman GJ, Thames HD et al (2004) Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients. J Natl Cancer Inst 96:1676–1681
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Missohou, F., Trombetta, M., Pignol, JP. (2017). Whole-Breast Hypofractionated Radiotherapy. In: Trombetta, M., Pignol, JP., Montemaggi, P., Brady, L.W. (eds) Alternate Fractionation in Radiotherapy. Medical Radiology(). Springer, Cham. https://doi.org/10.1007/174_2017_33
Download citation
DOI: https://doi.org/10.1007/174_2017_33
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-51197-9
Online ISBN: 978-3-319-51198-6
eBook Packages: MedicineMedicine (R0)